-
3 days ago | 
medicalnewstoday.com | Amber Watson
It’s not known whether Xywav (calcium, magnesium, potassium, and sodium oxybates) is safe to take while pregnant or breastfeeding. Certain factors, including the risks of not treating your condition during pregnancy may determine whether you should take the drug during this time. It’s not known whether you should take Xywav during pregnancy.
-
3 weeks ago | 
medicalnewstoday.com | Amber Watson
Gomekli is a brand-name drug prescribed for certain noncancerous tumors. The medication is available as an oral capsule and oral tablet. Specifically, the Food and Drug Administration (FDA) has approved Gomekli to treat neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN). With this condition, noncancerous tumors grow on nerves outside the brain and spinal cord. Gomekli is used to treat NF1-PN in certain adults and children ages 2 years and older.
-
3 weeks ago | 
medicalnewstoday.com | Amber Watson
Cefdinir has possible interactions with some other drugs and certain supplements. Examples include birth control pills and certain antacids. Talk with your doctor to avoid potentially harmful effects from cefdinir interactions.
-
1 month ago | 
medicalnewstoday.com | Amber Watson
Nexlizet (bempedoic acid/ezetimibe) may not be safe to take while pregnant or breastfeeding. Certain factors, including the risks of not treating your condition, may determine whether you should take the drug during this time. If you may be or can become pregnant, it’s important to consider whether Nexlizet is a safe option for you. It isn’t known whether Nexlizet is safe to take during pregnancy. Experts haven’t studied its effects during pregnancy.
-
1 month ago | 
medicalnewstoday.com | Amber Watson
Brukinsa has possible interactions with some other drugs and certain supplements. Examples include warfarin (Jantoven) and ciprofloxacin (Cipro). Talk with your doctor to avoid potentially harmful effects from Brukinsa interactions. Brukinsa is available as an oral capsule. It’s prescribed for the following conditions in adults in certain situations:An interaction occurs when one substance causes another substance to have a different effect than expected.
-
1 month ago | 
medicalnewstoday.com | Amber Watson
Simponi (golimumab) is a brand-name subcutaneous injection that’s prescribed for ulcerative colitis. This article covers topics such as side effects, dosage, and how Simponi works. Simponi is a biologic and belongs to a drug class called tumor necrosis factor (TNF) blockers. The medication is not available in a biosimilar version. Read on for more information about Simponi. You can also refer to this other article for a comprehensive look at Simponi and its other uses. Simponi has boxed warnings.
-
1 month ago | 
medicalnewstoday.com | Amber Watson
Nucala (mepolizumab) and Dupixent (dupilumab) are brand-name subcutaneous injections. They’re both prescribed for asthma and chronic rhinosinusitis with nasal polyps. Each drug may also be prescribed for other uses. This article explains the main similarities and differences between Nucala and Dupixent. If you’re considering treatment with one of these drugs, discussing this information with your doctor can help you decide if one of these drugs may be right for you.
-
1 month ago | 
medicalnewstoday.com | Amber Watson
Armour Thyroid (desiccated thyroid) is safe to take while pregnant or breastfeeding. Certain factors, including the risks of not treating your condition during pregnancy, may determine whether you should take the drug during this time. If you may be or can become pregnant, it’s important to consider whether Armour Thyroid is a safe option for you.
-
1 month ago | 
medicalnewstoday.com | Amber Watson
CellCept (mycophenolate mofetil) is not safe to take while pregnant or breastfeeding. Certain factors, including the risks of fetal harm and pregnancy loss, may determine whether you should take the drug during this time. CellCept is a brand-name drug prescribed to help prevent organ rejection after a heart, kidney, or liver transplant. It’s approved for use in adults and children ages 3 months and older.
-
1 month ago | 
medicalnewstoday.com | Amber Watson
Imbruvica (ibrutinib) is a brand-name drug that’s prescribed for chronic lymphocytic leukemia (CLL). This article covers topics such as side effects, dosage, and how Imbruvica works. Imbruvica is available in these forms: oral capsule, oral tablet, and oral suspension. Imbruvica belongs to a drug class called kinase inhibitors. The medication is not available in a generic version. Read on for more information about Imbruvica.
